
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_5{left:89px;top:104px;letter-spacing:-0.1px;word-spacing:3.2px;}
#t2_5{left:89px;top:119px;}
#t3_5{left:106px;top:119px;}
#t4_5{left:75px;top:145px;word-spacing:15.6px;}
#t5_5{left:89px;top:160px;word-spacing:5.3px;}
#t6_5{left:89px;top:176px;word-spacing:1.2px;}
#t7_5{left:89px;top:191px;word-spacing:4px;}
#t8_5{left:248px;top:191px;}
#t9_5{left:260px;top:191px;}
#ta_5{left:75px;top:216px;word-spacing:14.2px;}
#tb_5{left:89px;top:232px;word-spacing:27.7px;}
#tc_5{left:89px;top:247px;word-spacing:21.9px;}
#td_5{left:89px;top:262px;letter-spacing:-0.4px;}
#te_5{left:131px;top:262px;}
#tf_5{left:141px;top:262px;word-spacing:2.2px;}
#tg_5{left:275px;top:262px;}
#th_5{left:287px;top:262px;}
#ti_5{left:75px;top:288px;letter-spacing:-0.1px;word-spacing:18.9px;}
#tj_5{left:89px;top:303px;}
#tk_5{left:172px;top:303px;}
#tl_5{left:229px;top:303px;}
#tm_5{left:257px;top:303px;}
#tn_5{left:297px;top:303px;}
#to_5{left:89px;top:318px;word-spacing:21.6px;}
#tp_5{left:89px;top:333px;}
#tq_5{left:117px;top:333px;}
#tr_5{left:135px;top:333px;}
#ts_5{left:69px;top:359px;letter-spacing:-0.1px;word-spacing:2.8px;}
#tt_5{left:88px;top:374px;word-spacing:19.2px;}
#tu_5{left:88px;top:389px;letter-spacing:-0.1px;word-spacing:21.6px;}
#tv_5{left:88px;top:405px;word-spacing:10.9px;}
#tw_5{left:88px;top:420px;}
#tx_5{left:117px;top:420px;}
#ty_5{left:134px;top:420px;}
#tz_5{left:69px;top:446px;letter-spacing:-0.2px;word-spacing:6.7px;}
#t10_5{left:88px;top:461px;word-spacing:20.1px;}
#t11_5{left:88px;top:476px;word-spacing:15.5px;}
#t12_5{left:88px;top:491px;letter-spacing:-0.1px;word-spacing:3.1px;}
#t13_5{left:88px;top:506px;word-spacing:3.9px;}
#t14_5{left:141px;top:506px;}
#t15_5{left:158px;top:506px;}
#t16_5{left:69px;top:532px;letter-spacing:-0.1px;word-spacing:11.5px;}
#t17_5{left:88px;top:547px;word-spacing:2.9px;}
#t18_5{left:88px;top:563px;word-spacing:2.4px;}
#t19_5{left:88px;top:578px;word-spacing:21.4px;}
#t1a_5{left:88px;top:593px;word-spacing:4.2px;}
#t1b_5{left:88px;top:608px;word-spacing:6px;}
#t1c_5{left:88px;top:623px;}
#t1d_5{left:105px;top:623px;}
#t1e_5{left:69px;top:649px;word-spacing:22.1px;}
#t1f_5{left:88px;top:664px;word-spacing:15.6px;}
#t1g_5{left:88px;top:680px;word-spacing:8.8px;}
#t1h_5{left:353px;top:104px;word-spacing:18.8px;}
#t1i_5{left:353px;top:119px;word-spacing:11.7px;}
#t1j_5{left:353px;top:135px;word-spacing:4px;}
#t1k_5{left:425px;top:135px;}
#t1l_5{left:447px;top:135px;}
#t1m_5{left:333px;top:165px;word-spacing:5.7px;}
#t1n_5{left:353px;top:180px;word-spacing:25.2px;}
#t1o_5{left:353px;top:195px;word-spacing:2px;}
#t1p_5{left:558px;top:195px;}
#t1q_5{left:353px;top:210px;}
#t1r_5{left:333px;top:240px;word-spacing:9.5px;}
#t1s_5{left:353px;top:256px;word-spacing:12.4px;}
#t1t_5{left:353px;top:271px;word-spacing:4.4px;}
#t1u_5{left:353px;top:286px;word-spacing:3.9px;}
#t1v_5{left:440px;top:286px;}
#t1w_5{left:458px;top:286px;}
#t1x_5{left:333px;top:316px;letter-spacing:-0.2px;word-spacing:23.1px;}
#t1y_5{left:353px;top:331px;word-spacing:4.4px;}
#t1z_5{left:353px;top:346px;word-spacing:9.4px;}
#t20_5{left:353px;top:362px;word-spacing:8.8px;}
#t21_5{left:558px;top:362px;}
#t22_5{left:353px;top:377px;}
#t23_5{left:333px;top:407px;letter-spacing:-0.1px;word-spacing:10.1px;}
#t24_5{left:353px;top:422px;word-spacing:9px;}
#t25_5{left:353px;top:437px;word-spacing:24.1px;}
#t26_5{left:353px;top:453px;word-spacing:3.9px;}
#t27_5{left:436px;top:453px;}
#t28_5{left:448px;top:453px;}
#t29_5{left:333px;top:482px;letter-spacing:-0.1px;word-spacing:9.9px;}
#t2a_5{left:353px;top:498px;word-spacing:10.1px;}
#t2b_5{left:353px;top:513px;word-spacing:1.3px;}
#t2c_5{left:563px;top:513px;}
#t2d_5{left:353px;top:528px;}
#t2e_5{left:333px;top:558px;word-spacing:15.2px;}
#t2f_5{left:353px;top:573px;word-spacing:14.4px;}
#t2g_5{left:353px;top:589px;word-spacing:21px;}
#t2h_5{left:353px;top:604px;word-spacing:3.9px;}
#t2i_5{left:471px;top:604px;}
#t2j_5{left:488px;top:604px;}
#t2k_5{left:333px;top:634px;word-spacing:13.5px;}
#t2l_5{left:353px;top:649px;word-spacing:11.4px;}
#t2m_5{left:353px;top:664px;word-spacing:4.7px;}
#t2n_5{left:353px;top:680px;}
#t2o_5{left:365px;top:680px;}
#t2p_5{left:598px;top:104px;word-spacing:11.1px;}
#t2q_5{left:618px;top:119px;word-spacing:5.3px;}
#t2r_5{left:618px;top:135px;}
#t2s_5{left:646px;top:135px;}
#t2t_5{left:664px;top:135px;}
#t2u_5{left:598px;top:160px;word-spacing:6px;}
#t2v_5{left:618px;top:176px;word-spacing:2.5px;}
#t2w_5{left:618px;top:191px;word-spacing:12.5px;}
#t2x_5{left:618px;top:206px;}
#t2y_5{left:640px;top:206px;}
#t2z_5{left:598px;top:232px;letter-spacing:-0.1px;word-spacing:10.1px;}
#t30_5{left:618px;top:247px;word-spacing:16.8px;}
#t31_5{left:618px;top:262px;word-spacing:3.9px;}
#t32_5{left:749px;top:262px;}
#t33_5{left:772px;top:262px;}
#t34_5{left:598px;top:288px;letter-spacing:-0.2px;word-spacing:7.7px;}
#t35_5{left:618px;top:303px;word-spacing:12.1px;}
#t36_5{left:618px;top:318px;word-spacing:1.5px;}
#t37_5{left:618px;top:333px;word-spacing:3.9px;}
#t38_5{left:678px;top:333px;}
#t39_5{left:701px;top:333px;}
#t3a_5{left:598px;top:359px;letter-spacing:-0.1px;word-spacing:0.5px;}
#t3b_5{left:618px;top:374px;word-spacing:13.1px;}
#t3c_5{left:618px;top:389px;word-spacing:19.4px;}
#t3d_5{left:618px;top:405px;word-spacing:1px;}
#t3e_5{left:618px;top:420px;letter-spacing:-0.1px;word-spacing:7.3px;}
#t3f_5{left:618px;top:435px;letter-spacing:-0.1px;word-spacing:3.8px;}
#t3g_5{left:618px;top:450px;}
#t3h_5{left:635px;top:450px;}
#t3i_5{left:598px;top:476px;word-spacing:8.4px;}
#t3j_5{left:618px;top:491px;word-spacing:-1.5px;}
#t3k_5{left:618px;top:506px;word-spacing:1.5px;}
#t3l_5{left:618px;top:522px;}
#t3m_5{left:640px;top:522px;}
#t3n_5{left:598px;top:547px;word-spacing:7.8px;}
#t3o_5{left:618px;top:563px;word-spacing:7.9px;}
#t3p_5{left:618px;top:578px;word-spacing:19px;}
#t3q_5{left:618px;top:593px;word-spacing:3.9px;}
#t3r_5{left:760px;top:593px;}
#t3s_5{left:777px;top:593px;}
#t3t_5{left:598px;top:619px;letter-spacing:-0.1px;word-spacing:23.6px;}
#t3u_5{left:618px;top:634px;word-spacing:15.5px;}
#t3v_5{left:618px;top:649px;word-spacing:14.6px;}
#t3w_5{left:618px;top:664px;word-spacing:12px;}
#t3x_5{left:618px;top:680px;word-spacing:3.8px;}
#t3y_5{left:730px;top:680px;}
#t3z_5{left:747px;top:680px;}
#t40_5{left:139px;top:36px;word-spacing:4.8px;}
#t41_5{left:813px;top:36px;}

.s3_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: IIBMGD-AdvPSSym5;
	color: rgb(0,0,0);
}

.s5_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: IIBMDK-AdvPSA35F5;
	color: rgb(0,0,0);
}

.s4_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: IIBMGE-AdvPSA35B5;
	color: rgb(0,0,0);
}

.s1_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: IIBMFB-AdvPS_UVCL5;
	color: rgb(0,0,0);
}

.s2_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: IIBNJA-AdvOTda3b4f5f-B5;
	color: rgb(0,0,0);
}

</style>
<style id="fonts5" type="text/css" >

@font-face {
	font-family: IIBMGD-AdvPSSym5;
	src: url("5/fonts/IIBMGD-AdvPSSym.woff") format("woff");
}

@font-face {
	font-family: IIBMGE-AdvPSA35B5;
	src: url("5/fonts/IIBMGE-AdvPSA35B.woff") format("woff");
}

@font-face {
	font-family: IIBNJA-AdvOTda3b4f5f-B5;
	src: url("5/fonts/IIBNJA-AdvOTda3b4f5f-B.woff") format("woff");
}

@font-face {
	font-family: IIBMDK-AdvPSA35F5;
	src: url("5/fonts/IIBMDK-AdvPSA35F.woff") format("woff");
}

@font-face {
	font-family: IIBMFB-AdvPS_UVCL5;
	src: url("5/fonts/IIBMFB-AdvPS_UVCL.woff") format("woff");
}

</style>
<div id="t1_5" class="t s1_5">Rotterdam study. J Clin Endocrinol Metab 2002;</div>
<div id="t2_5" class="t s2_5">87:</div>
<div id="t3_5" class="t s1_5">3632.</div>
<div id="t4_5" class="t s1_5">7. Rhoden EL and Morgentaler A: Symptomatic</div>
<div id="t5_5" class="t s1_5">response rates to testosterone therapy and the</div>
<div id="t6_5" class="t s1_5">likelihood of completing 12 months of therapy in</div>
<div id="t7_5" class="t s1_5">clinical practice. J Sex Med 2010;</div>
<div id="t8_5" class="t s2_5">7:</div>
<div id="t9_5" class="t s1_5">277.</div>
<div id="ta_5" class="t s1_5">8. McCullough AR, Khera M, Goldstein I et al:</div>
<div id="tb_5" class="t s1_5">A multi-institutional observational study of</div>
<div id="tc_5" class="t s1_5">testosterone levels after testosterone pellet</div>
<div id="td_5" class="t s1_5">(Testopel(</div>
<div id="te_5" class="t s3_5">Ã’</div>
<div id="tf_5" class="t s1_5">)) insertion. J Sex Med 2012;</div>
<div id="tg_5" class="t s2_5">9:</div>
<div id="th_5" class="t s1_5">594.</div>
<div id="ti_5" class="t s1_5">9. Pastuszak AW, Mittakanti H, Liu JS et al:</div>
<div id="tj_5" class="t s1_5">Pharmacokinetic</div>
<div id="tk_5" class="t s1_5">evaluation</div>
<div id="tl_5" class="t s1_5">and</div>
<div id="tm_5" class="t s1_5">dosing</div>
<div id="tn_5" class="t s1_5">of</div>
<div id="to_5" class="t s1_5">subcutaneous testosterone pellets. J Androl</div>
<div id="tp_5" class="t s1_5">2012;</div>
<div id="tq_5" class="t s2_5">33:</div>
<div id="tr_5" class="t s1_5">927.</div>
<div id="ts_5" class="t s1_5">10. Marbury T, Hamill E, Bachand R et al: Evaluation</div>
<div id="tt_5" class="t s1_5">of the pharmacokinetic profiles of the new</div>
<div id="tu_5" class="t s1_5">testosterone topical gel formulation, Testim,</div>
<div id="tv_5" class="t s1_5">compared to AndroGel. Biopharm Drug Dispos</div>
<div id="tw_5" class="t s1_5">2003;</div>
<div id="tx_5" class="t s2_5">24:</div>
<div id="ty_5" class="t s1_5">115.</div>
<div id="tz_5" class="t s1_5">11. Smith RP, Khanna A, Coward RM et al: Factors</div>
<div id="t10_5" class="t s1_5">influencing patient decisions to initiate and</div>
<div id="t11_5" class="t s1_5">discontinue subcutaneous testosterone pellets</div>
<div id="t12_5" class="t s1_5">(Testopel) for treatment of hypogonadism. J Sex</div>
<div id="t13_5" class="t s1_5">Med 2013;</div>
<div id="t14_5" class="t s2_5">10:</div>
<div id="t15_5" class="t s1_5">2326.</div>
<div id="t16_5" class="t s1_5">12. Heufelder AE, Saad F, Bunck MC et al: Fifty-</div>
<div id="t17_5" class="t s1_5">two-week treatment with diet and exercise plus</div>
<div id="t18_5" class="t s1_5">transdermal testosterone reverses the metabolic</div>
<div id="t19_5" class="t s1_5">syndrome and improves glycemic control in</div>
<div id="t1a_5" class="t s1_5">men with newly diagnosed type 2 diabetes and</div>
<div id="t1b_5" class="t s1_5">subnormal plasma testosterone. J Androl 2009;</div>
<div id="t1c_5" class="t s2_5">30:</div>
<div id="t1d_5" class="t s1_5">726.</div>
<div id="t1e_5" class="t s1_5">13. Haider A, Gooren LJ, Padungtod P et al:</div>
<div id="t1f_5" class="t s1_5">Improvement of the metabolic syndrome and</div>
<div id="t1g_5" class="t s1_5">of non-alcoholic liver steatosis upon treatment</div>
<div id="t1h_5" class="t s1_5">of hypogonadal elderly men with parenteral</div>
<div id="t1i_5" class="t s1_5">testosterone undecanoate. Exp Clin Endocrinol</div>
<div id="t1j_5" class="t s1_5">Diabetes 2010;</div>
<div id="t1k_5" class="t s2_5">118:</div>
<div id="t1l_5" class="t s1_5">167.</div>
<div id="t1m_5" class="t s1_5">14. Morley J, Charlton E, Patrick P et al: Validation</div>
<div id="t1n_5" class="t s1_5">of a screening questionnaire for androgen</div>
<div id="t1o_5" class="t s1_5">deficiency in aging males. Metabolism 2000;</div>
<div id="t1p_5" class="t s2_5">49:</div>
<div id="t1q_5" class="t s1_5">1239.</div>
<div id="t1r_5" class="t s1_5">15. Mohamed O, Freundlich R, Dakik H et al: The</div>
<div id="t1s_5" class="t s1_5">quantitative ADAM questionnaire: a new tool</div>
<div id="t1t_5" class="t s1_5">in quantifying the severity of hypogonadism. Int</div>
<div id="t1u_5" class="t s1_5">J Impot Res 2010;</div>
<div id="t1v_5" class="t s2_5">22:</div>
<div id="t1w_5" class="t s1_5">20.</div>
<div id="t1x_5" class="t s1_5">16. Yamaguchi K, Ishikawa T, Chiba K et al:</div>
<div id="t1y_5" class="t s1_5">Assessment of possible effects for testosterone</div>
<div id="t1z_5" class="t s1_5">replacement therapy in men with symptomatic</div>
<div id="t20_5" class="t s1_5">late-onset hypogonadism. Andrologia 2011;</div>
<div id="t21_5" class="t s2_5">43:</div>
<div id="t22_5" class="t s1_5">52.</div>
<div id="t23_5" class="t s1_5">17. Taylor F and Levine L: Clomiphene citrate and</div>
<div id="t24_5" class="t s1_5">testosterone gel replacement therapy for male</div>
<div id="t25_5" class="t s1_5">hypogonadism: efficacy and treatment cost.</div>
<div id="t26_5" class="t s1_5">J Sex Med 2010;</div>
<div id="t27_5" class="t s2_5">7:</div>
<div id="t28_5" class="t s1_5">269.</div>
<div id="t29_5" class="t s1_5">18. Shabsigh A, Kang Y, Shabsign R et al: Clomi-</div>
<div id="t2a_5" class="t s1_5">phene citrate effects on testosterone/estrogen</div>
<div id="t2b_5" class="t s1_5">ratio in male hypogonadism. J Sex Med 2005;</div>
<div id="t2c_5" class="t s2_5">2:</div>
<div id="t2d_5" class="t s1_5">716.</div>
<div id="t2e_5" class="t s1_5">19. Whitten S, Nangia A and Kolettis P: Select</div>
<div id="t2f_5" class="t s1_5">patients with hypogonadotropic hypogonadism</div>
<div id="t2g_5" class="t s1_5">may respond to treatment with clomiphene</div>
<div id="t2h_5" class="t s1_5">citrate. Fertil Steril 2006;</div>
<div id="t2i_5" class="t s2_5">86:</div>
<div id="t2j_5" class="t s1_5">1664.</div>
<div id="t2k_5" class="t s1_5">20. Goldstein S, Siddhanti S, Ciaccia A et al: A</div>
<div id="t2l_5" class="t s1_5">pharmacological review of selective oestrogen</div>
<div id="t2m_5" class="t s1_5">receptor modulators. Hum Reprod Update 2000;</div>
<div id="t2n_5" class="t s2_5">6:</div>
<div id="t2o_5" class="t s1_5">212.</div>
<div id="t2p_5" class="t s1_5">21. Willets A, Corbo J and Brown J: Clomiphene</div>
<div id="t2q_5" class="t s1_5">for the treatment of male infertility. Reprod Sci</div>
<div id="t2r_5" class="t s1_5">2013;</div>
<div id="t2s_5" class="t s2_5">20:</div>
<div id="t2t_5" class="t s1_5">739.</div>
<div id="t2u_5" class="t s1_5">22. Moskovic DJ, Katz DJ, Akhavan A et al: Clomi-</div>
<div id="t2v_5" class="t s1_5">phene citrate is safe and effective for long-term</div>
<div id="t2w_5" class="t s1_5">management of hypogonadism. BJU Int 2012;</div>
<div id="t2x_5" class="t s2_5">110:</div>
<div id="t2y_5" class="t s1_5">1524.</div>
<div id="t2z_5" class="t s1_5">23. Katz DJ, Nabulsi O, Tal R et al: Outcomes of</div>
<div id="t30_5" class="t s1_5">clomiphene citrate treatment in young hypo-</div>
<div id="t31_5" class="t s1_5">gonadal men. BJU Int 2012;</div>
<div id="t32_5" class="t s2_5">110:</div>
<div id="t33_5" class="t s1_5">573.</div>
<div id="t34_5" class="t s1_5">24. Ko EY, Siddiqi K, Brannigan RE et al: Empirical</div>
<div id="t35_5" class="t s1_5">medical therapy for idiopathic male infertility:</div>
<div id="t36_5" class="t s1_5">a survey of the American Urological Association.</div>
<div id="t37_5" class="t s1_5">J Urol 2012;</div>
<div id="t38_5" class="t s2_5">187:</div>
<div id="t39_5" class="t s1_5">973.</div>
<div id="t3a_5" class="t s1_5">25. Yeap BB, Alfonso H, Chubb SA et al: In older men</div>
<div id="t3b_5" class="t s1_5">an optimal plasma testosterone is associated</div>
<div id="t3c_5" class="t s1_5">with reduced all-cause mortality and higher</div>
<div id="t3d_5" class="t s1_5">dihydrotestosterone with reduced ischemic heart</div>
<div id="t3e_5" class="t s1_5">disease mortality, while estradiol levels do not</div>
<div id="t3f_5" class="t s1_5">predict mortality. J Clin Endocrinol Metab 2014;</div>
<div id="t3g_5" class="t s2_5">99:</div>
<div id="t3h_5" class="t s1_5">E9.</div>
<div id="t3i_5" class="t s1_5">26. Finkelstein JS, Lee H, Burnett-Bowie SA et al:</div>
<div id="t3j_5" class="t s1_5">Gonadal steroids and body composition, strength,</div>
<div id="t3k_5" class="t s1_5">and sexual function in men. N Engl J Med 2013;</div>
<div id="t3l_5" class="t s2_5">369:</div>
<div id="t3m_5" class="t s1_5">1011.</div>
<div id="t3n_5" class="t s1_5">27. Hajjar RR, Kaiser FE and Morley JE: Outcomes</div>
<div id="t3o_5" class="t s1_5">of long-term testosterone replacement in older</div>
<div id="t3p_5" class="t s1_5">hypogonadal males: a retrospective analysis.</div>
<div id="t3q_5" class="t s1_5">J Clin Endocrinol Metab 1997;</div>
<div id="t3r_5" class="t s2_5">82:</div>
<div id="t3s_5" class="t s1_5">3793.</div>
<div id="t3t_5" class="t s1_5">28. Harman SM, Metter EJ, Tobin JD et al:</div>
<div id="t3u_5" class="t s1_5">Longitudinal effects of aging on serum total</div>
<div id="t3v_5" class="t s1_5">and free testosterone levels in healthy men.</div>
<div id="t3w_5" class="t s1_5">Baltimore Longitudinal Study of Aging. J Clin</div>
<div id="t3x_5" class="t s1_5">Endocrinol Metab 2001;</div>
<div id="t3y_5" class="t s2_5">86:</div>
<div id="t3z_5" class="t s1_5">724.</div>
<div id="t40_5" class="t s4_5">TESTOSTERONE SUPPLEMENTATION VERSUS CLOMIPHENE CITRATE FOR HYPOGONADISM</div>
<div id="t41_5" class="t s5_5">879</div>

<div id="pg5Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg5"><object width="893" height="1196" data="5/5.svg" type="image/svg+xml" id="pdf5" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 146;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_5");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
